Lupin Labs

Rediff.com » News » Lupin Labs

News for Lupin Labs

Business

Pricing challenge in US biz, rich valuations may weigh on pharma stocks

The tailwind of low price erosion in the US generics market, seen by domestic pharmaceutical companies in calendar year 2023 (CY23), may be reversing slowly, caution analysts. Illustration: Uttam......

Lupin Labs and EU foray

Lupin has announced its fourth quarter results. The company's Q4 net profit is up at Rs 50.19 crore as against Rs 21.73 crore. Its revenues are up at Rs 463 crore from Rs 299.48 crore. MD of Lupin......

Budget 2023: What the pharma, healthcare industry seek

The government should take measures to promote innovation and R&D while simplifying regulations for the sector in the upcoming Union Budget, as per pharmaceutical industry bodies. Illustration:......

Pharma shares boost markets; Dr Reddy's Labs, Lupin lead

Markets ended higher on Thursday after Dr Reddy's Labs strategic tie-up with Amgen fuelled a rally in pharma shares while capital goods shares firmed up on renewed buying interest. India which......

Pharma body to get free hand at pricing

The government has hinted that medicine price regulator National Pharmaceutical Pricing Authority (NPPA) will be given a free hand to control prices of medicines, including those normally out of......

Rediff News

Lupin Labs

News for Lupin Labs

Pricing challenge in US biz, rich valuations may weigh on pharma stocks

Lupin Labs and EU foray

Budget 2023: What the pharma, healthcare industry seek

Pharma shares boost markets; Dr Reddy's Labs, Lupin lead

Pharma body to get free hand at pricing

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS